1. Combining conventional therapy with immunotherapy: A risky business?. (May 2019) Authors: Coosemans, A.; Vankerckhoven, A.; Baert, T.; Boon, L.; Ruts, H.; Riva, M.; Blagden, S.; Delforge, M.; Concin, N.; Mirza, M.R.; Ledermann, J.A.; du Bois, A.; Vergote, I. Journal: European journal of cancer Issue: Volume 113(2019) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 00054 CLINICAL RELEVANCE OF DOMINANT-NEGATIVE P73 ISOFORMS FOR RESPONSIVENESS TO CHEMOTHERAPY AND SURVIVAL IN OVARIAN CANCER - EVIDENCE FOR A CRUCIAL P53-P73 CROSS-TALK IN VIVO. (1st September 2005) Authors: Concin, N.; Hofstetter, G.; Berger, A.; Gehmacher, A.; Reimer, D.; Watrowsky, R.; Tong, D.; Hefler, L.; Heim, K.; Mueller-Holzner, E.; Marth, C.; Zeimet, A. G.; Moll, U.; Zeillinger, R. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP-0155 Surgical aspects. (August 2021) Authors: Concin, N. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SP-0153 Introduction to the ESGO-ESTRO-ESP guidelines and methodology. (August 2021) Authors: Concin, N. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors. (10th June 2021) Authors: Timmerman, D.; Planchamp, F.; Bourne, T.; Landolfo, C.; du Bois, A.; Chiva, L.; Cibula, D.; Concin, N.; Fischerova, D.; Froyman, W.; Gallardo, G.; Lemley, B.; Loft, A.; Mereu, L.; Morice, P.; Querleu, D.; Testa, A. C.; Vergote, I.; Vandecaveye, V.; Scambia, G. Journal: Ultrasound in obstetrics & gynecology Issue: Volume 58:Number 1(2021) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Jump in the fire — heat shock proteins and their impact on ovarian cancer therapy. (January 2016) Authors: Stope, M.B.; Koensgen, D.; Burchardt, M.; Concin, N.; Zygmunt, M.; Mustea, A. Journal: Critical reviews in oncology/hematology Issue: Volume 97(2016) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy of CDK 4/6 inhibition after fulvestrant in metastatic breast cancer. (April 2018) Authors: Hoste, G.; Punie, K.; Wildiers, H.; Neven, P.; Vergote, I.; Beuselinck, B.; Concin, N.; Han, S.; Van Nieuwenhuysen, E.; Salihi, R.; Smeets, A.; Berteloot, P.; Lefever, I.; Nevelsteen, I.; Van Limbergen, E.; Weltens, C.; Janssen, H. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗